Sable
Payments companies reported to CMS as associated with Sable. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Sable, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Sable
These are the largest totals companies reported as associated with Sable. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Dorchak | Columbus, GA | Orthopaedic Surgery | $2,074,196.82 |
| Choll Kim | San Diego, CA | Orthopaedic Surgery of The Spine | $1,053,479.76 |
| Akhil Khanna | Washington, DC | Orthopaedic Surgery | $1,042,109.82 |
| Christopher Tomaras | Atlanta, GA | Neurological Surgery | $1,038,927.54 |
| David Skaggs | Los Angeles, CA | Orthopaedic Surgery | $18,900.00 |
| Jeffrey Goldstein | New York, NY | Orthopaedic Surgery of The Spine | $13,169.91 |
| Rakesh Patel | Ann Arbor, MI | Orthopaedic Surgery | $12,907.20 |
| Victor Chang | Detroit, MI | Neurological Surgery | $11,810.55 |
| Paul Park | Memphis, TN | Neurological Surgery | $11,552.15 |
| Jessica Aidlen | Newton, MA | Orthopaedic Surgery | $11,500.00 |
Prescribed Sable?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.